Orgenesis Inc. announced that it has entered into a securities purchase agreement to issue 1,410,256 shares at a price of $0.78 per unit and warrants at a price of $1.1 million on November 8, 2023. The warrants will be exercisable immediately following the date of issuance and may be exercised for a period of five years from the initial exercisability date at an exercise price of $0.78 per share. The transaction is expected to close on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 USD | -9.56% | -8.72% | -6.13% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-6.13% | 16.18M | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it expects to receive $1.1 million in funding